Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
192M
-
Number of holders
-
549
-
Total 13F shares, excl. options
-
183M
-
Shares change
-
-2.8M
-
Total reported value, excl. options
-
$16B
-
Value change
-
-$290M
-
Put/Call ratio
-
1.02
-
Number of buys
-
250
-
Number of sells
-
-248
-
Price
-
$87.34
Significant Holders of BIOMARIN PHARMACEUTICAL INC - COM (BMRN) as of Q1 2024
656 filings reported holding BMRN - BIOMARIN PHARMACEUTICAL INC - COM as of Q1 2024.
BIOMARIN PHARMACEUTICAL INC - COM (BMRN) has 549 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 183M shares
of 192M outstanding shares and own 95.69% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (18.7M shares), VANGUARD GROUP INC (18.1M shares), BlackRock Inc. (14.5M shares), Dodge & Cox (14M shares), STATE STREET CORP (6.9M shares), Capital Research Global Investors (6.52M shares), VIKING GLOBAL INVESTORS LP (6.42M shares), AMERIPRISE FINANCIAL INC (5.4M shares), BARCLAYS PLC (5.25M shares), and UBS Group AG (5.06M shares).
This table shows the top 549 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.